Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_assertion description "[We demonstrate the clinical usefulness of a panel of beta2 integrins (CD11a, CD11b and CD11c) in accurate prediction of AML-M3, and recommend inclusion of this immunophenotypic analysis to identify patients who require ATRA therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_assertion evidence source_evidence_literature NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_assertion SIO_000772 16764927 NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_assertion wasDerivedFrom befree-20150227 NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_assertion wasGeneratedBy ECO_0000203 NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP517419.RAErgE5QpbFzzDA_ju4qnEf2lgx527PrUixvMZ2aheTi8130_provenance.